Weil Company’s Corteva CTVA Stock Holding History

Weil Company’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,127	Closed	-$32K	–	161
2019 Q3	$32K	Buy	+1,127	New	+$32.6K	0.02%	218

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Weil Company's CTVA Position: Q4 2019 in Review

Weil Company sold out of Corteva (CTVA) in Q4 2019, closing a stake of 1,127 shares — an estimated $32K sold.

Weil Company first reported a position in CTVA in Q3 2019 and held it in 1 quarter. The position peaked at $32K in Q3 2019. 1,006 funds tracked by Wall St. Rank hold CTVA as of Q4 2019.

Weil Company reported no remaining Corteva position as of Q4 2019 after selling out during the quarter.
Weil Company sold 1,127 Corteva shares in Q4 2019, an estimated $32K.
Weil Company first reported a position in Corteva in Q3 2019 and held it in 1 quarter.
Weil Company's Corteva position peaked at $32K in Q3 2019.
1,006 funds tracked by Wall St. Rank held Corteva as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.